Tri-vylibra Lo
Product Images NDC 53002-1778

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tri-vylibra Lo (NDC 53002-1778). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl530021778)

Tri-VyLibra Lo tablets 28-day pack label from RPK Pharmaceuticals, Inc. The label includes dosing instructions to take one tablet daily, product identification with multiple NDC codes, and placeholders for clinic and patient information. Packaging indicates a 28-day supply for the Tri-VyLibra Lo regimen.*

FDA Label Image

Blister Pack Label (Norgestimate Fig1)

An instructional diagram showing the weekly dosage schedule for Tri-VyLibra Lo tablets (norgestimate and ethinyl estradiol). It displays four rows labeled Week 1 to Week 4 with colored circles representing tablets: white to off-white for Week 1, pale blue to bluish white for Week 2, blue to light blue for Week 3, and green for Week 4. The diagram aligns the tablets with days of the week from Sunday to Saturday and indicates the start point for tablet intake.*

FDA Label Image

Day Label Sticker (Norgestimate Fig2)

An instructional diagram for Tri-VyLibra Lo tablets demonstrating how to apply a correct day-of-week label strip to a 28-pill birth control pack. Pills are color-coded in rows by weeks with four different shades indicating placebo and active tablets, annotated with active ingredients norgestimate and ethinyl estradiol strengths. A hand is shown peeling the labeled strip to place it appropriately on the pack.*

FDA Label Image

Pregnancy Chart (Norgestimate Fig3)

An illustration diagram showing a vertical scale of pregnancy rates per 100 women in one year, ranging from fewer than 1 to 85 or more pregnancies. Various contraceptive methods are listed alongside the scale, organized by effectiveness in reducing pregnancies. These include implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, vaginal ring with hormones, condoms, diaphragm, no sex during fertile days, spermicide, withdrawal, and no birth control.*

FDA Label Image

Blister Pack Label1 (Norgestimate Fig4)

An instructional diagram for Tri-VyLibra Lo tablets arranged by week and day in a 4-week cycle. It shows colored circles indicating tablet appearance by week: white to off-white for week 1, pale blue to bluish white for week 2, blue to light blue for week 3 with dosages specified, and green for week 4.*

FDA Label Image

Day Label Sticker1 (Norgestimate Fig5)

An instructional diagram showing how to peel and place the correct day label on a weekly oral contraceptive blister card for Tri-VyLibra Lo by RPK Pharmaceuticals, Inc. The image depicts a hand positioning a day label over the days of the week above four rows of tablets. Each row corresponds to a week and contains circular tablets in different color shades, from white/off-white to green, labeled with the active ingredients noregestimate and ethinyl estradiol and their respective dosages for each week.*

FDA Label Image

Chemical Structure (Norgestimate Str)

Chemical structure diagram showing the molecular formulas of Norgestimate and Ethinyl Estradiol, the active ingredients likely present in the product Tri-VyLibra Lo by RPK Pharmaceuticals, Inc. Each structure displays atom arrangement and bonding specific to the compound named below it.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.